Dysregulation of Serum Gamma Interferon Levels in Vascular Chronic Q Fever Patients Provides Insights into Disease Pathogenesis

ABSTRACT A large community outbreak of Q fever occurred in the Netherlands in the period 2007 to 2010. Some of the infected patients developed chronic Q fever, which typically includes pathogen dissemination to predisposed cardiovascular sites, with potentially fatal consequences. To identify the immune mechanisms responsible for ineffective clearance of Coxiella burnetii in patients who developed chronic Q fever, we compared serum concentrations of 47 inflammation-associated markers among patients with acute Q fever, vascular chronic Q fever, and past resolved Q fever. Serum levels of gamma interferon were strongly increased in acute but not in vascular chronic Q fever patients, compared to past resolved Q fever patients. Interleukin-18 levels showed a comparable increase in acute as well as vascular chronic Q fever patients. Additionally, vascular chronic Q fever patients had lower serum levels of gamma interferon-inducible protein 10 (IP-10) and transforming growth factor β (TGF-β) than did acute Q fever patients. Serum responses for these and other markers indicate that type I immune responses to C. burnetii are affected in chronic Q fever patients. This may be attributed to an affected immune system in cardiovascular patients, which enables local C. burnetii replication at affected cardiovascular sites.

[1]  F. Moll,et al.  Estimated prevalence of chronic Q fever among Coxiella burnetii seropositive patients with an abdominal aortic/iliac aneurysm or aorto-iliac reconstruction after a large Dutch Q fever outbreak. , 2014, The Journal of infection.

[2]  N. Renders,et al.  Histological characteristics of the abdominal aortic wall in patients with vascular chronic Q fever , 2014, International journal of experimental pathology.

[3]  J. Oosterheert,et al.  Chronic Q Fever in the Netherlands 5 Years after the Start of the Q Fever Epidemic: Results from the Dutch Chronic Q Fever Database , 2014, Journal of Clinical Microbiology.

[4]  R. Janssen,et al.  Correlations between Peripheral Blood Coxiella burnetii DNA Load, Interleukin-6 Levels, and C-Reactive Protein Levels in Patients with Acute Q Fever , 2014, Clinical and Vaccine Immunology.

[5]  K. van der Velden,et al.  Assessing the long-term health impact of Q-fever in the Netherlands: a prospective cohort study started in 2007 on the largest documented Q-fever outbreak to date , 2012, BMC Infectious Diseases.

[6]  L. Joosten,et al.  IL-18 serum concentration is markedly elevated in acute EBV infection and can serve as a marker for disease severity. , 2012, The Journal of infectious diseases.

[7]  J. Oosterheert,et al.  Prevalence of Chronic Q Fever in Patients with a History of Cardiac Valve Surgery in an Area Where Coxiella burnetii Is Epidemic , 2012, Clinical and Vaccine Immunology.

[8]  M. Koopmans,et al.  Chronic Q fever: review of the literature and a proposal of new diagnostic criteria. , 2012, The Journal of infection.

[9]  Y. V. van Duynhoven,et al.  Shifting priorities in the aftermath of a Q fever epidemic in 2007 to 2009 in The Netherlands: from acute to chronic infection. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[10]  C. Rodríguez-Gallego,et al.  Successful management of chronic multifocal Q fever Osteomyelitis with adjuvant interferon-gamma therapy. , 2011, The Pediatric infectious disease journal.

[11]  J. Hibbert,et al.  CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications , 2011, Cytokine & Growth Factor Reviews.

[12]  D. Aeschlimann,et al.  TNFalpha and TGF-beta1 influence IL-18-induced IFNgamma production through regulation of IL-18 receptor and T-bet expression. , 2010, Cytokine.

[13]  E. V. van Hannen,et al.  Real-Time PCR with Serum Samples Is Indispensable for Early Diagnosis of Acute Q Fever , 2009, Clinical and Vaccine Immunology.

[14]  R. Flavell,et al.  Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. , 2009, Current opinion in pharmacology.

[15]  B. Roep Faculty Opinions recommendation of Transforming growth factor-beta suppresses the activation of CD8+ T-cells when naive but promotes their survival and function once antigen experienced: a two-faced impact on autoimmunity. , 2008 .

[16]  R. Flavell,et al.  Transforming Growth Factor- Suppresses the Activation of CD8 T-Cells When Naı̈ve but Promotes Their Survival and Function Once Antigen Experienced A Two-Faced Impact on Autoimmunity , 2008 .

[17]  M. Caligiuri,et al.  TGF-β Utilizes SMAD3 to Inhibit CD16-Mediated IFN-γ Production and Antibody-Dependent Cellular Cytotoxicity in Human NK Cells1 , 2008, The Journal of Immunology.

[18]  D. Raoult,et al.  The Uptake of Apoptotic Cells Drives Coxiella burnetii Replication and Macrophage Polarization: A Model for Q Fever Endocarditis , 2008, PLoS pathogens.

[19]  Alain Bernard,et al.  Coxiella burnetii, the agent of Q fever, stimulates an atypical M2 activation program in human macrophages , 2008, European journal of immunology.

[20]  M. Russo,et al.  Role of Endogenous IFN-γ in Macrophage Programming Induced by IL-12 and IL-18 , 2007 .

[21]  J. Samuel,et al.  T Cells Are Essential for Bacterial Clearance, and Gamma Interferon, Tumor Necrosis Factor Alpha, and B Cells Are Crucial for Disease Development in Coxiella burnetii Infection in Mice , 2007, Infection and Immunity.

[22]  D. Raoult,et al.  Deficient transendothelial migration of leukocytes in Q fever: the role played by interleukin-10. , 2006, The Journal of infectious diseases.

[23]  D. Raoult,et al.  IL-16 Is Critical for Tropheryma whipplei Replication in Whipple’s Disease1 , 2005, The Journal of Immunology.

[24]  D. Raoult,et al.  Natural history and pathophysiology of Q fever. , 2005, The Lancet. Infectious diseases.

[25]  R. de Waal Malefyt,et al.  IL‐12 and IL‐23: master regulators of innate and adaptive immunity , 2004, Immunological reviews.

[26]  Masahiro Yamamura,et al.  Use of Genetic Profiling in Leprosy to Discriminate Clinical Forms of the Disease , 2003, Science.

[27]  T. van der Poll,et al.  Reduced interferon-γ release in patients recovered from Legionnaires' disease , 2003, Thorax.

[28]  Barry S. Fields,et al.  Legionella and Legionnaires' Disease: 25 Years of Investigation , 2002, Clinical Microbiology Reviews.

[29]  H. Wakiguchi,et al.  Intractable Q fever treated with recombinant gamma interferon. , 2001, The Pediatric infectious disease journal.

[30]  J. Brieland,et al.  Immunomodulatory Role of Endogenous Interleukin-18 in Gamma Interferon-Mediated Resolution of Replicative Legionella pneumophila Lung Infection , 2000, Infection and Immunity.

[31]  C. Dinarello Interleukin-18, a proinflammatory cytokine. , 2000, European cytokine network.

[32]  D. Raoult,et al.  IFN-gamma-mediated control of Coxiella burnetii survival in monocytes: the role of cell apoptosis and TNF. , 1999, Journal of immunology.

[33]  D. Raoult,et al.  Production of interleukin-10 and transforming growth factor beta by peripheral blood mononuclear cells in Q fever endocarditis , 1996, Infection and immunity.

[34]  H. Murray Interferon-gamma, the activated macrophage, and host defense against microbial challenge. , 1988, Annals of internal medicine.

[35]  M. Caligiuri,et al.  TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells. , 2008, Journal of immunology.

[36]  R. Flavell,et al.  TGF- β suppresses the activation of CD8 + T cells when naïve but promotes their survival and function once antigen-experienced: a two-faced impact on autoimmunity , 2008 .

[37]  M. Russo,et al.  Role of endogenous IFN-gamma in macrophage programming induced by IL-12 and IL-18. , 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[38]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[39]  H. Okamura,et al.  Cloning of a new cytokine that induces IFN-gamma production by T cells. , 1995, Nature.

[40]  F Nistal de Paz,et al.  [Q fever]. , 1994, Medicina clinica.

[41]  E. Derrick The Query Fever. The Elkington Oration. , 1964 .